GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

BACKGROUND: TNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Huaying, Yan, Tingting, Lu, Xinxin, Du, Yueyao, Xu, Shuguang, Kong, Yu, Yu, Liangjie, Sun, Jian, Zhou, Liheng, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585280/
https://www.ncbi.nlm.nih.gov/pubmed/36275705
http://dx.doi.org/10.3389/fimmu.2022.1033367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585280/
https://www.ncbi.nlm.nih.gov/pubmed/36275705
http://dx.doi.org/10.3389/fimmu.2022.1033367

Ejemplares similares